Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

    Robert A. Wild, Enrico Carmina, Evanthia Diamanti-Kandarakis, Anuja Dokras, Héctor F. Escobar-Morreale, Walter Futterweit, Rogerio A. Løbo, Robert J. Norman, Evelyn O. Talbott, Daniel A. Dumesic
    Image of study
    TLDR Women with PCOS should be screened for heart disease risk and manage their health to prevent it.
    The 2010 consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society concluded that women with PCOS are at an increased risk for cardiovascular disease (CVD), particularly if they have additional risk factors such as obesity, smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease. The statement recommended comprehensive screening for CVD risk factors in women with PCOS, including body mass index, waist circumference, serum lipid/glucose levels, and blood pressure, with oral glucose tolerance testing for those at higher risk. Lifestyle management was advised as the primary prevention strategy for CVD, with the potential addition of insulin-sensitizing and other drugs if necessary. The document also noted the presence of mood disorders as independent risk factors for CVD in PCOS patients and suggested that early and ongoing CVD risk assessment and prevention are crucial. It mentioned the inconsistent data on metformin's effects on CVD prevention, the potential benefits of statins, and the options of antihypertensives, antiobesity drugs, and bariatric surgery for weight management. The guidelines provided are not guaranteed to ensure specific outcomes or establish standards of care.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 11 months ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 11 months ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 4 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    5 / 5 results